LAM
TRIB

Lapides Asset Management’s Trinity Biotech TRIB Stock Holding History

Lapides Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,370
Closed -$1.08M – 75
2019
Q2 		$1.08M Sell
4,370
-1
-0% -$357 0.5% 51
2019
Q1 		$1.87M Buy
4,371
+92
+2% +$37.9K 0.71% 44
2018
Q4 		$1.47M Sell
4,279
-3,535
-45% -$1.64M 0.6% 46
2018
Q3 		$4.69M Sell
7,814
-421
-5% -$274K 1.02% 38
2018
Q2 		$6.18M Buy
8,235
+156
+2% +$113K 1.31% 29
2018
Q1 		$6.24M Buy
8,079
+256
+3% +$210K 1.37% 29
2017
Q4 		$5.98M Sell
7,823
-774
-9% -$599K 1.3% 32
2017
Q3 		$7.24M Hold
8,597
– – 1.48% 26
2017
Q2 		$7.74M Buy
8,597
+36
+0.4% +$30.6K 1.5% 24
2017
Q1 		$7.65M Buy
8,561
+769
+10% +$721K 1.44% 28
2016
Q4 		$8.09M Buy
7,792
+3,101
+66% +$3.2M 1.45% 24
2016
Q3 		$9.3M Sell
4,691
-10
-0.2% -$18.7K 1.58% 23
2016
Q2 		$8M Hold
4,701
– – 1.48% 22
2016
Q1 		$8.22M Buy
4,701
+1,006
+27% +$1.6M 1.47% 26
2015
Q4 		$6.52M Buy
3,695
+1,232
+50% +$2.18M 1.14% 30
2015
Q3 		$4.23M Buy
2,463
+451
+22% +$1.09M 0.73% 50
2015
Q2 		$5.45M Buy
2,012
+851
+73% +$2.21M 0.87% 39
2015
Q1 		$3.35M Sell
1,161
-388
-25% -$1.08M 0.56% 58
2014
Q4 		$4.07M Buy
+1,549
New +$4M 0.55% 55

Other funds holding TRIB

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Lapides Asset Management's TRIB Position: Q3 2019 in Review

Lapides Asset Management sold out of Trinity Biotech (TRIB) in Q3 2019, closing a stake of 4,370 shares — an estimated $1.08M sold.

Lapides Asset Management first reported a position in TRIB in Q4 2014 and held it in 19 quarters. The position peaked at $9.3M in Q3 2016. 28 funds tracked by Wall St. Rank hold TRIB as of Q3 2019.

  • Lapides Asset Management reported no remaining Trinity Biotech position as of Q3 2019 after selling out during the quarter.
  • Lapides Asset Management sold 4,370 Trinity Biotech shares in Q3 2019, an estimated $1.08M.
  • Lapides Asset Management first reported a position in Trinity Biotech in Q4 2014 and held it in 19 quarters.
  • Lapides Asset Management's Trinity Biotech position peaked at $9.3M in Q3 2016.
  • 28 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2019.

Based on Lapides Asset Management's 13F filing for Q3 2019, filed 30 Oct 2019.